Literature DB >> 8574953

A "complement-ary" AIDS vaccine.

M P Dierich1, H Stoiber, A Clivio.   

Abstract

The human immunodeficiency virus uses the human complement system to its advantage. Is it possible to turn the tables with a vaccine?

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8574953     DOI： 10.1038/nm0296-153

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


  6 in total

Review 1.  The good and evil of complement activation in HIV-1 infection.

Authors:  Qigui Yu; Richard Yu; Xuebin Qin
Journal:  Cell Mol Immunol       Date:  2010-03-15       Impact factor: 11.530

Review 2.  Complement and HIV-I infection/HIV-associated neurocognitive disorders.

Authors:  Fengming Liu; Shen Dai; Jennifer Gordon; Xuebin Qin
Journal:  J Neurovirol       Date:  2014-03-18       Impact factor: 2.643

3.  Provirus activation plus CD59 blockage triggers antibody-dependent complement-mediated lysis of latently HIV-1-infected cells.

Authors:  Jie Lan; Kai Yang; Daniel Byrd; Ningjie Hu; Tohti Amet; Nicole Shepherd; Mona Desai; Jimin Gao; Samir Gupta; Yongtao Sun; Qigui Yu
Journal:  J Immunol       Date:  2014-08-22       Impact factor: 5.422

4.  Glycosylphosphatidylinositol Anchor Deficiency Attenuates the Production of Infectious HIV-1 and Renders Virions Sensitive to Complement Attack.

Authors:  Tohti Amet; Jie Lan; Nicole Shepherd; Kai Yang; Daniel Byrd; Yanyan Xing; Qigui Yu
Journal:  AIDS Res Hum Retroviruses       Date:  2016-07-27       Impact factor: 2.205

5.  A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement.

Authors:  Leili Jia; Yuanyong Xu; Chuanfu Zhang; Yong Wang; Huihui Chong; Shaofu Qiu; Ligui Wang; Yanwei Zhong; Weijing Liu; Yansong Sun; Fei Qiao; Stephen Tomlinson; Hongbin Song; Yusen Zhou; Yuxian He
Journal:  Virol J       Date:  2010-06-29       Impact factor: 4.099

6.  A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS.

Authors:  Weiguo Hu; Qigui Yu; Ningjie Hu; Daniel Byrd; Tohti Amet; Cecilia Shikuma; Bruce Shiramizu; Jose A Halperin; Xuebin Qin
Journal:  J Immunol       Date:  2009-12-02       Impact factor: 5.422
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.